Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01842087 · ClinicalTrials.gov registry record · NA

The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients

A NA study of Chronic Kidney Disease, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01842087: Completed NA study of Chronic Kidney Disease, sponsored by University of Florida.

NCT01842087 is a NA study of Chronic Kidney Disease that has completed, run by University of Florida. The registered enrollment target is 15 participants, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01842087, a NA study of Chronic Kidney Disease, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

A single blind, six week dietary intervention will be conducted in order to evaluate the impact of fiber fortified foods on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function.

Primary Outcome

Blood samples (10 mL) will be taken on day 1, 14, 28, and 42. BUN will be assayed using the Urea Nitrogen Concentrated Reagent method.

Conditions Studied

Interventions

  • OTHER Control Food
  • OTHER Fiber Fortified Food

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2010-04
Est. Completion 2010-11
Phase NA
University of Florida

1,106 total trials

What the finished NCT01842087 record still lists

NCT01842087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which Control Food is the first listed.

NCT01842087 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01842087 about?

NCT01842087 is a clinical study titled "The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients". A single blind, six week dietary intervention will be conducted in order to evaluate the impact of fiber fortified foods on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function.

What is the current status of trial NCT01842087?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2010-04. Estimated completion is 2010-11.

What conditions does trial NCT01842087 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT01842087?

The interventions under investigation include: Control Food (OTHER), Fiber Fortified Food (OTHER).

Who is sponsoring clinical trial NCT01842087?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01842087 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01842087's enrollment target sits among peer trials

15 94th of 101 higher than 6 of 101 other Chronic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01842087, the US trial registry maintained by the National Library of Medicine. NCT01842087 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.